Multiple Myeloma:@0.747978:0.035749:0.914540:0.035749:0.914540:0.019993:0.747978:0.019993:0.017684:0.011699:0.003848:0.006523:0.003848:0.013123:0.003848:0.012508:0.005330:0.017684:0.010314:0.012508:0.003848:0.012604:0.018049:0.013143
TREATMENT APPROACHES:@0.983689:0.278245:0.983689:0.065272:0.955679:0.065272:0.955679:0.278245:0.000000:0.000000:0.000000:0.057096:-0.123230:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.375913
85:@0.955522:0.038184:0.976595:0.038184:0.976595:0.018587:0.955522:0.018587:0.010536:0.010536
HANDBOOK OF ONCOLOGY:@0.679047:0.970015:0.915156:0.970015:0.915156:0.956010:0.679047:0.956010:0.011682:0.012657:0.012657:0.012726:0.009818:0.014864:0.014864:0.010109:0.004738:0.014864:0.008296:0.004738:0.014864:0.012657:0.013906:0.014864:0.007902:0.014864:0.014915:0.010126
Dr K Antel:@0.084242:0.158666:0.175067:0.158666:0.175067:0.142632:0.084242:0.142632:0.013470:0.006158:0.005388:0.011930:0.005388:0.014239:0.011545:0.005773:0.012315:0.004618
MBChB, FCP (SA), MMed (Int Med), Cert :@0.084242:0.174871:0.456775:0.174871:0.456775:0.158652:0.084242:0.158652:0.017318:0.011161:0.015009:0.011545:0.011161:0.005388:0.005388:0.009236:0.015009:0.010776:0.005388:0.007312:0.010006:0.014239:0.007312:0.005388:0.005388:0.017318:0.017318:0.012315:0.012700:0.005388:0.007312:0.005388:0.011545:0.005773:0.005388:0.017318:0.012315:0.012700:0.007312:0.005388:0.005388:0.015009:0.012315:0.006158:0.005773:0.005388
Clin Haem (Phys):@0.084242:0.191077:0.243570:0.191077:0.243570:0.174858:0.084242:0.174858:0.015009:0.004618:0.004618:0.011545:0.005388:0.013085:0.012700:0.012315:0.018088:0.005388:0.007312:0.010776:0.011545:0.011161:0.008467:0.007312
 :@0.084242:0.207164:0.120630:0.207164:0.120630:0.192479:0.084242:0.192479:0.017145:0.019242
Clinical Haematologist, UCT :@0.120630:0.207283:0.383115:0.207283:0.383115:0.191527:0.120630:0.191527:0.015644:0.003848:0.003848:0.011738:0.003848:0.012450:0.013143:0.003848:0.005330:0.013143:0.013143:0.012508:0.018049:0.013143:0.006523:0.012604:0.003848:0.012604:0.012950:0.003848:0.007466:0.006523:0.005330:0.005330:0.012604:0.015644:0.008197:0.005330
Department of Medicine, Division of :@0.084242:0.223489:0.423832:0.223489:0.423832:0.207733:0.084242:0.207733:0.014316:0.012508:0.013123:0.013143:0.005792:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330:0.012604:0.006042:0.005330:0.017684:0.012508:0.013181:0.003848:0.012450:0.003848:0.011738:0.012508:0.005330:0.005330:0.014316:0.003848:0.010660:0.003848:0.007466:0.003848:0.012604:0.011738:0.005330:0.012604:0.006042:0.005330
Haematology:@0.084242:0.239694:0.213070:0.239694:0.213070:0.223938:0.084242:0.223938:0.013143:0.013143:0.012508:0.018049:0.013143:0.006523:0.012604:0.003848:0.012604:0.012950:0.010314
Prof VJ Louw:@0.084242:0.272092:0.200082:0.272092:0.200082:0.256059:0.084242:0.256059:0.010776:0.006158:0.012315:0.005388:0.005388:0.013470:0.009236:0.005388:0.008467:0.012315:0.011545:0.015394
MBChB, MMed (Int Med), FCP(SA), :@0.084242:0.288298:0.406745:0.288298:0.406745:0.272079:0.084242:0.272079:0.017318:0.011161:0.015009:0.011545:0.011161:0.005388:0.005388:0.017318:0.017318:0.012315:0.012700:0.005388:0.007312:0.005388:0.011545:0.005773:0.005388:0.017318:0.012315:0.012700:0.007312:0.005388:0.005388:0.009236:0.015009:0.010776:0.007312:0.010006:0.014239:0.007312:0.005388:0.005388
PhD(HPE):@0.084242:0.304504:0.168524:0.304504:0.168524:0.288285:0.084242:0.288285:0.010776:0.011545:0.013470:0.007312:0.013085:0.010776:0.010006:0.007312
 :@0.084242:0.320591:0.120630:0.320591:0.120630:0.305906:0.084242:0.305906:0.017145:0.019242
Honorary Professor Clinical :@0.120630:0.320710:0.371684:0.320710:0.371684:0.304954:0.120630:0.304954:0.013143:0.012604:0.011738:0.012604:0.005792:0.013143:0.005792:0.010314:0.005330:0.011392:0.005694:0.012604:0.006042:0.012508:0.007466:0.007466:0.012604:0.005792:0.005330:0.015644:0.003848:0.003848:0.011738:0.003848:0.012450:0.013143:0.003848:0.005330
Haematology, UCT Department of :@0.084242:0.336915:0.409035:0.336915:0.409035:0.321159:0.084242:0.321159:0.013143:0.013143:0.012508:0.018049:0.013143:0.006523:0.012604:0.003848:0.012604:0.012950:0.010314:0.005330:0.005330:0.012604:0.015644:0.008197:0.005330:0.014316:0.012508:0.013123:0.013143:0.005792:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330:0.012604:0.006042:0.005330
Medicine, Division of Haematology:@0.084242:0.353121:0.409131:0.353121:0.409131:0.337365:0.084242:0.337365:0.017684:0.012508:0.013181:0.003848:0.012450:0.003848:0.011738:0.012508:0.005330:0.005330:0.014316:0.003848:0.010660:0.003848:0.007466:0.003848:0.012604:0.011738:0.005330:0.012604:0.006042:0.005330:0.013143:0.013143:0.012508:0.018049:0.013143:0.006523:0.012604:0.003848:0.012604:0.012950:0.010314
Dr E Verburgh:@0.084242:0.385519:0.211242:0.385519:0.211242:0.369486:0.084242:0.369486:0.013470:0.006158:0.005388:0.010006:0.005388:0.013470:0.012315:0.006158:0.012700:0.011545:0.006158:0.012700:0.011545
MB ChB MMed FCP PhD:@0.084242:0.401725:0.302451:0.401725:0.302451:0.385506:0.084242:0.385506:0.017318:0.011161:0.005388:0.015009:0.011545:0.011161:0.005388:0.017318:0.017318:0.012315:0.012700:0.005388:0.009236:0.015009:0.010776:0.005388:0.010776:0.011545:0.013470
 :@0.084242:0.417812:0.120630:0.417812:0.120630:0.403127:0.084242:0.403127:0.017145:0.019242
Senior Specialist, Division of Clinical :@0.120630:0.417931:0.450368:0.417931:0.450368:0.402175:0.120630:0.402175:0.009583:0.012508:0.011738:0.003848:0.012604:0.005792:0.005330:0.009583:0.013123:0.012508:0.012450:0.003848:0.013143:0.003848:0.003848:0.007466:0.006523:0.005330:0.005330:0.014316:0.003848:0.010660:0.003848:0.007466:0.003848:0.012604:0.011738:0.005330:0.012604:0.006042:0.005330:0.015644:0.003848:0.003848:0.011738:0.003848:0.012450:0.013143:0.003848:0.005330
Haematology, Department of Medicine, :@0.084242:0.434137:0.465685:0.434137:0.465685:0.418381:0.084242:0.418381:0.013143:0.013143:0.012508:0.018049:0.013143:0.006523:0.012604:0.003848:0.012604:0.012950:0.010314:0.005330:0.005330:0.014316:0.012508:0.013123:0.013143:0.005792:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330:0.012604:0.006042:0.005330:0.017684:0.012508:0.013181:0.003848:0.012450:0.003848:0.011738:0.012508:0.005330:0.005330
University of Cape Town:@0.084242:0.450342:0.306175:0.450342:0.306175:0.434586:0.084242:0.434586:0.012604:0.011738:0.003848:0.010660:0.012508:0.005792:0.007466:0.003848:0.006523:0.010314:0.005330:0.012604:0.006042:0.005330:0.015644:0.013143:0.013123:0.012508:0.005330:0.007245:0.012604:0.015990:0.011738
Multiple  myeloma  (MM)  is  a  neoplasm  of :@0.084242:0.482740:0.480467:0.482740:0.480467:0.466985:0.084242:0.466985:0.017106:0.011122:0.003271:0.005946:0.003271:0.012546:0.003271:0.011930:0.005330:0.005011:0.017472:0.009737:0.011930:0.003271:0.012027:0.017472:0.012565:0.005330:0.005011:0.006523:0.017106:0.017106:0.006523:0.005330:0.005011:0.003271:0.006889:0.005330:0.005011:0.012565:0.005330:0.005009:0.011161:0.011930:0.012027:0.012546:0.003271:0.012565:0.006889:0.017472:0.005330:0.005011:0.012027:0.006040:0.005330
plasma cells characterised by plasma-cell :@0.084242:0.498946:0.480428:0.498946:0.480428:0.483190:0.084242:0.483190:0.012546:0.003271:0.012565:0.006889:0.017472:0.012565:0.010237:0.011873:0.011930:0.003271:0.003271:0.006889:0.010237:0.011873:0.011161:0.012565:0.005215:0.012565:0.011873:0.005946:0.011930:0.005215:0.003271:0.006889:0.011930:0.012604:0.010237:0.012546:0.009737:0.010237:0.012546:0.003271:0.012565:0.006889:0.017472:0.012565:0.005811:0.011873:0.011930:0.003271:0.003852:0.005330
proliferation in the bone marrow with the pro-:@0.084242:0.515152:0.475165:0.515152:0.475165:0.499396:0.084242:0.499396:0.012546:0.005136:0.012027:0.003271:0.003271:0.005465:0.011930:0.005215:0.012565:0.005946:0.003271:0.012027:0.011161:0.003887:0.003271:0.011161:0.003887:0.005946:0.011161:0.011930:0.003887:0.012546:0.012027:0.011161:0.011930:0.003887:0.017472:0.012565:0.005215:0.005136:0.012027:0.015413:0.003887:0.015413:0.003271:0.005946:0.011161:0.003887:0.005946:0.011161:0.011930:0.003887:0.012546:0.005136:0.012027:0.006388
duction of a monoclonal immunoglobulin. :@0.084242:0.531358:0.480478:0.531358:0.480478:0.515602:0.084242:0.515602:0.012604:0.011122:0.011873:0.005946:0.003271:0.012027:0.011161:0.009775:0.012027:0.005465:0.009775:0.012565:0.009775:0.017472:0.012027:0.011161:0.012027:0.011873:0.003271:0.012027:0.011161:0.012565:0.003271:0.009775:0.003271:0.017472:0.017472:0.011122:0.011161:0.012027:0.012373:0.003271:0.012027:0.012546:0.011122:0.003271:0.003271:0.011161:0.005326:0.005330
Plasma cells are post-germinal centre B-cells :@0.084242:0.547563:0.480463:0.547563:0.480463:0.531807:0.084242:0.531807:0.010814:0.003271:0.012565:0.006889:0.017472:0.012565:0.005474:0.011873:0.011930:0.003271:0.003271:0.006889:0.005474:0.012565:0.005136:0.011930:0.005474:0.012546:0.012027:0.006889:0.005946:0.005811:0.012373:0.011930:0.005746:0.017472:0.003271:0.011161:0.012565:0.003271:0.005474:0.011873:0.011930:0.011161:0.005946:0.005136:0.011930:0.005474:0.010468:0.005811:0.011873:0.011930:0.003271:0.003271:0.007468:0.005330
that produce antibodies. The clinical fea-:@0.084242:0.563769:0.475167:0.563769:0.475167:0.548013:0.084242:0.548013:0.005946:0.011161:0.012565:0.005946:0.010699:0.012546:0.005134:0.012027:0.012604:0.011122:0.011873:0.011930:0.010699:0.012565:0.011161:0.005946:0.003271:0.012546:0.012027:0.012604:0.003271:0.011930:0.006889:0.004753:0.010699:0.007620:0.011161:0.011930:0.010699:0.011873:0.003271:0.003271:0.011161:0.003271:0.011873:0.012565:0.003271:0.010699:0.005465:0.011930:0.012565:0.006388
tures of myeloma result from bone-marrow :@0.084242:0.579975:0.480492:0.579975:0.480492:0.564219:0.084242:0.564219:0.005946:0.011122:0.005136:0.011930:0.006889:0.008332:0.012027:0.005465:0.008332:0.017472:0.009737:0.011930:0.003271:0.012027:0.017472:0.012565:0.008332:0.005134:0.011930:0.006889:0.011122:0.003271:0.005946:0.008332:0.005465:0.005134:0.012027:0.017472:0.008332:0.012546:0.012027:0.011161:0.011930:0.005811:0.017472:0.012565:0.005215:0.005136:0.012027:0.015992:0.005330
invasion, cytokine release with stimulation of :@0.084242:0.596181:0.480480:0.596181:0.480480:0.580425:0.084242:0.580425:0.003271:0.011161:0.010083:0.012565:0.006889:0.003271:0.012027:0.011161:0.004753:0.006052:0.011873:0.009737:0.005946:0.012027:0.009082:0.003271:0.011161:0.011930:0.006050:0.005136:0.011930:0.003271:0.011930:0.012565:0.006889:0.011930:0.006050:0.015413:0.003271:0.005946:0.011161:0.006050:0.006889:0.005946:0.003271:0.017472:0.011122:0.003271:0.012565:0.005946:0.003271:0.012027:0.011161:0.006050:0.012027:0.006040:0.005330
osteoclastic activity, and the clinical conse-:@0.084242:0.612386:0.475142:0.612386:0.475142:0.596630:0.084242:0.596630:0.012027:0.006889:0.005946:0.011930:0.012027:0.011873:0.003271:0.012565:0.006889:0.005946:0.003271:0.011873:0.006552:0.012565:0.011873:0.005946:0.003271:0.010083:0.003271:0.005946:0.009737:0.004753:0.006552:0.012565:0.011161:0.012604:0.006552:0.005946:0.011161:0.011930:0.006552:0.011873:0.003271:0.003271:0.011161:0.003271:0.011873:0.012565:0.003271:0.006552:0.011873:0.012027:0.011161:0.006889:0.011930:0.006388
quences of excessive immunoglobulin.:@0.084242:0.628592:0.423794:0.628592:0.423794:0.612836:0.084242:0.612836:0.012546:0.011122:0.011930:0.011161:0.011873:0.011930:0.006889:0.004753:0.012027:0.005465:0.004753:0.011930:0.008659:0.011873:0.011930:0.006889:0.006889:0.003271:0.010083:0.011930:0.004753:0.003271:0.017472:0.017472:0.011122:0.011161:0.012027:0.012373:0.003271:0.012027:0.012546:0.011122:0.003271:0.003271:0.011161:0.005330
The  production  of  a  monoclonal  immu-:@0.102426:0.644798:0.475179:0.644798:0.475179:0.629042:0.102426:0.629042:0.007620:0.011161:0.011930:0.005330:0.005009:0.012546:0.005136:0.012027:0.012604:0.011122:0.011873:0.005946:0.003271:0.012027:0.011161:0.005330:0.005009:0.012027:0.005465:0.005330:0.005009:0.012565:0.005330:0.005009:0.017472:0.012027:0.011161:0.012027:0.011873:0.003271:0.012027:0.011161:0.012565:0.003271:0.005330:0.005009:0.003271:0.017472:0.017472:0.011122:0.006388
noglobulin (M-protein) is also seen in lym-:@0.084242:0.661004:0.475150:0.661004:0.475150:0.645248:0.084242:0.645248:0.011161:0.012027:0.012373:0.003271:0.012027:0.012546:0.011122:0.003271:0.003271:0.011161:0.010429:0.006523:0.017106:0.005811:0.012546:0.005136:0.012027:0.005946:0.011930:0.003271:0.011161:0.006523:0.010429:0.003271:0.006889:0.010429:0.012565:0.003271:0.006889:0.012027:0.010429:0.006889:0.011930:0.011930:0.011161:0.010429:0.003271:0.011161:0.010429:0.003271:0.009737:0.017472:0.006388
phoma, other haematological malignancies :@0.084242:0.677209:0.480513:0.677209:0.480513:0.661453:0.084242:0.661453:0.012546:0.011161:0.012027:0.017472:0.012565:0.004753:0.004483:0.012027:0.005946:0.011161:0.011930:0.005215:0.004483:0.011161:0.012565:0.011930:0.017472:0.012565:0.005946:0.012027:0.003271:0.012027:0.012373:0.003271:0.011873:0.012565:0.003271:0.004474:0.017472:0.012565:0.003271:0.003271:0.012373:0.011161:0.012565:0.011161:0.011873:0.003271:0.011930:0.007468:0.005330
and two plasma-cell dyscrasias: monoclonal :@0.084242:0.693415:0.480447:0.693415:0.480447:0.677659:0.084242:0.677659:0.012565:0.011161:0.012604:0.004753:0.005946:0.015413:0.012027:0.004753:0.012546:0.003271:0.012565:0.006889:0.017472:0.012565:0.005811:0.011873:0.011930:0.003271:0.003271:0.004753:0.012604:0.009737:0.006889:0.011873:0.005215:0.012565:0.006889:0.003271:0.012565:0.006889:0.004753:0.004753:0.017472:0.012027:0.011161:0.012027:0.011873:0.003271:0.012027:0.011161:0.012565:0.003852:0.005330
gammopathy of undetermined significance :@0.084242:0.709621:0.480499:0.709621:0.480499:0.693865:0.084242:0.693865:0.012373:0.012565:0.017472:0.017472:0.012027:0.012546:0.012565:0.005946:0.011161:0.009737:0.005653:0.012027:0.005465:0.005653:0.011122:0.011161:0.012604:0.011930:0.005946:0.011930:0.005746:0.017472:0.003271:0.011161:0.011930:0.012604:0.005653:0.006889:0.003271:0.012373:0.011161:0.003271:0.004397:0.004397:0.011873:0.012565:0.011161:0.011873:0.012506:0.005330
(MGUS) and smouldering multiple myeloma :@0.084242:0.725826:0.480476:0.725826:0.480476:0.710070:0.084242:0.710070:0.006523:0.017106:0.016202:0.012027:0.009005:0.006523:0.006492:0.012565:0.011161:0.012604:0.006492:0.006889:0.017472:0.012027:0.011122:0.003271:0.012604:0.011930:0.005215:0.003271:0.011161:0.012373:0.006492:0.017472:0.011122:0.003271:0.005946:0.003271:0.012546:0.003271:0.011930:0.006492:0.017472:0.009737:0.011930:0.003271:0.012027:0.017472:0.013144:0.005330
(SMM). MGUS and SMM are considered :@0.084242:0.742032:0.480497:0.742032:0.480497:0.726276:0.084242:0.726276:0.006523:0.009005:0.017106:0.017106:0.006523:0.004753:0.013277:0.017106:0.016202:0.012027:0.009005:0.013277:0.012565:0.011161:0.012604:0.013277:0.009005:0.017106:0.017106:0.013277:0.012565:0.005136:0.011930:0.013277:0.011873:0.012027:0.011161:0.006889:0.003271:0.012604:0.011930:0.005136:0.011930:0.013181:0.005330
pre-malignant  conditions  on  the  pathway :@0.084242:0.758238:0.480494:0.758238:0.480494:0.742482:0.084242:0.742482:0.012546:0.005136:0.011930:0.005811:0.017472:0.012565:0.003271:0.003271:0.012373:0.011161:0.012565:0.011161:0.005946:0.005330:0.005357:0.011873:0.012027:0.011161:0.012604:0.003271:0.005946:0.003271:0.012027:0.011161:0.006889:0.005330:0.005357:0.012027:0.011161:0.005330:0.005357:0.005946:0.011161:0.011930:0.005330:0.005357:0.012546:0.012565:0.005946:0.011161:0.015413:0.012565:0.010316:0.005330
to myeloma, but vary greatly in their risk of :@0.084242:0.774444:0.480534:0.774444:0.480534:0.758688:0.084242:0.758688:0.005946:0.012027:0.007639:0.017472:0.009737:0.011930:0.003271:0.012027:0.017472:0.012565:0.004753:0.007639:0.012546:0.011122:0.005946:0.007639:0.010083:0.012565:0.005215:0.009737:0.007639:0.012373:0.005134:0.011930:0.012565:0.005946:0.003271:0.009737:0.007639:0.003271:0.011161:0.007639:0.005946:0.011161:0.011930:0.003271:0.005215:0.007639:0.005215:0.003271:0.006889:0.009082:0.007639:0.012027:0.006040:0.005330
progression. The approach to the diagnosis :@0.084242:0.790649:0.480517:0.790649:0.480517:0.774893:0.084242:0.774893:0.012546:0.005136:0.012027:0.012373:0.005136:0.011930:0.006889:0.006889:0.003271:0.012027:0.011161:0.004753:0.007408:0.007620:0.011161:0.011930:0.007408:0.012565:0.012546:0.012546:0.005134:0.012027:0.012565:0.011873:0.011161:0.007408:0.005946:0.012027:0.007408:0.005946:0.011161:0.011930:0.007408:0.012604:0.003271:0.012565:0.012373:0.011161:0.012027:0.006889:0.003271:0.007470:0.005330
and management of these conditions will be :@0.084242:0.806855:0.480461:0.806855:0.480461:0.791099:0.084242:0.791099:0.012565:0.011161:0.012604:0.004022:0.017472:0.012565:0.011161:0.012565:0.012373:0.011930:0.017472:0.011930:0.011161:0.005946:0.004022:0.012027:0.005465:0.004022:0.005946:0.011161:0.011930:0.006889:0.011930:0.004022:0.011873:0.012027:0.011161:0.012604:0.003271:0.005946:0.003271:0.012027:0.011161:0.006889:0.004022:0.015413:0.003271:0.003271:0.003271:0.004022:0.012546:0.012506:0.005330
briefly included in the discussion.:@0.084242:0.823061:0.367337:0.823061:0.367337:0.807305:0.084242:0.807305:0.012546:0.005215:0.003271:0.011930:0.004378:0.004378:0.009737:0.004753:0.003271:0.011161:0.011873:0.003271:0.011122:0.012604:0.011930:0.012604:0.004753:0.003271:0.011161:0.004753:0.005946:0.011161:0.011930:0.004753:0.012604:0.003271:0.006889:0.011873:0.011122:0.006889:0.006889:0.003271:0.012027:0.011161:0.005330
An increase in plasma cells and total im-:@0.102426:0.839267:0.475129:0.839267:0.475129:0.823511:0.102426:0.823511:0.013662:0.011161:0.007562:0.003271:0.011161:0.011873:0.005134:0.011930:0.012565:0.006889:0.011930:0.007562:0.003271:0.011161:0.007562:0.012546:0.003271:0.012565:0.006889:0.017472:0.012565:0.007562:0.011873:0.011930:0.003271:0.003271:0.006889:0.007562:0.012565:0.011161:0.012604:0.007562:0.005946:0.012027:0.005946:0.012565:0.003271:0.007562:0.003271:0.017472:0.006388
munoglobulin is seen in various benign con-:@0.084242:0.855472:0.475190:0.855472:0.475190:0.839716:0.084242:0.839716:0.017472:0.011122:0.011161:0.012027:0.012373:0.003271:0.012027:0.012546:0.011122:0.003271:0.003271:0.011161:0.006427:0.003271:0.006889:0.006427:0.006889:0.011930:0.011930:0.011161:0.006427:0.003271:0.011161:0.006427:0.010083:0.012565:0.005215:0.003271:0.012027:0.011122:0.006889:0.006427:0.012546:0.011930:0.011161:0.003271:0.012373:0.011161:0.006427:0.011873:0.012027:0.011161:0.006388
ditions (HIV and chronic inflammation), the :@0.084242:0.871678:0.480482:0.871678:0.480482:0.855922:0.084242:0.855922:0.012604:0.003271:0.005946:0.003271:0.012027:0.011161:0.006889:0.008115:0.006523:0.012565:0.003772:0.012931:0.008113:0.012565:0.011161:0.012604:0.008113:0.011873:0.011161:0.005134:0.012027:0.011161:0.003271:0.011873:0.008115:0.003271:0.011161:0.004378:0.004378:0.012565:0.017472:0.017472:0.012565:0.005946:0.003271:0.012027:0.011161:0.006523:0.004753:0.008115:0.005946:0.011161:0.012506:0.005330
distinguishing characteristic from MM is that :@0.084242:0.887884:0.480478:0.887884:0.480478:0.872128:0.084242:0.872128:0.012604:0.003271:0.006889:0.005946:0.003271:0.011161:0.012373:0.011122:0.003271:0.006889:0.011161:0.003271:0.011161:0.012373:0.007177:0.011873:0.011161:0.012565:0.005215:0.012565:0.011873:0.005946:0.011930:0.005215:0.003271:0.006889:0.005946:0.003271:0.011873:0.007177:0.005465:0.005136:0.012027:0.017472:0.007177:0.017106:0.017106:0.007177:0.003271:0.006889:0.007177:0.005946:0.011161:0.012565:0.006521:0.005330
plasma cells in benign conditions are poly-:@0.084242:0.904089:0.475169:0.904089:0.475169:0.888333:0.084242:0.888333:0.012546:0.003271:0.012565:0.006889:0.017472:0.012565:0.007947:0.011873:0.011930:0.003271:0.003271:0.006889:0.007947:0.003271:0.011161:0.007947:0.012546:0.011930:0.011161:0.003271:0.012373:0.011161:0.007947:0.011873:0.012027:0.011161:0.012604:0.003271:0.005946:0.003271:0.012027:0.011161:0.006889:0.007947:0.012565:0.005136:0.011930:0.007947:0.012546:0.012027:0.003271:0.009737:0.006388
clonal and produce an array of different im-:@0.084242:0.920295:0.475183:0.920295:0.475183:0.904539:0.084242:0.904539:0.011873:0.003271:0.012027:0.011161:0.012565:0.003271:0.005234:0.012565:0.011161:0.012604:0.005224:0.012546:0.005134:0.012027:0.012604:0.011122:0.011873:0.011930:0.005224:0.012565:0.011161:0.005224:0.012565:0.005215:0.005215:0.012565:0.009737:0.005234:0.012027:0.005465:0.005234:0.012604:0.003271:0.005521:0.005465:0.011930:0.005136:0.011930:0.011161:0.005946:0.005224:0.003271:0.017472:0.006388
munoglobulins.:@0.084242:0.936501:0.217284:0.936501:0.217284:0.920745:0.084242:0.920745:0.017472:0.011122:0.011161:0.012027:0.012373:0.003271:0.012027:0.012546:0.011122:0.003271:0.003271:0.011161:0.006889:0.005330
PREVALENCE OF DISEASE:@0.523636:0.158577:0.800684:0.158577:0.800684:0.138981:0.523636:0.138981:0.013170:0.013641:0.012230:0.016463:0.017404:0.010348:0.012230:0.017404:0.018344:0.012230:0.006585:0.019756:0.011289:0.006585:0.016463:0.006585:0.012230:0.012230:0.017404:0.012230:0.012230
In South Africa, the incidence rate taken :@0.523636:0.177573:0.919889:0.177573:0.919889:0.161817:0.523636:0.161817:0.004349:0.011738:0.007549:0.009583:0.012604:0.011699:0.006523:0.011726:0.007551:0.014239:0.006042:0.005792:0.003848:0.012450:0.013143:0.005330:0.007545:0.006523:0.011738:0.012508:0.007547:0.003848:0.011738:0.012450:0.003848:0.013181:0.012508:0.011738:0.012450:0.012508:0.007549:0.005792:0.013143:0.006523:0.012508:0.007543:0.006523:0.013143:0.009660:0.012508:0.011738:0.005330
from the latest published National Cancer :@0.523636:0.194281:0.919891:0.194281:0.919891:0.178526:0.523636:0.178526:0.006042:0.005711:0.012604:0.018049:0.005369:0.006523:0.011738:0.012508:0.005369:0.003848:0.013143:0.006523:0.012508:0.007466:0.006523:0.005369:0.013123:0.011699:0.013123:0.003848:0.003848:0.007466:0.011738:0.012508:0.013181:0.005369:0.014239:0.013143:0.006523:0.003848:0.012604:0.011738:0.013143:0.003848:0.005369:0.015644:0.013143:0.011738:0.012450:0.012508:0.005792:0.005330
Registry is 0.5/100 000,  however, in the US :@0.523636:0.210990:0.919892:0.210978:0.919892:0.195222:0.523636:0.195234:0.011680:0.012508:0.012950:0.003848:0.007466:0.006523:0.005792:0.010314:0.006331:0.003848:0.007466:0.006331:0.010660:0.005330:0.010660:0.008409:0.010660:0.010660:0.010660:0.006342:0.010660:0.010660:0.010660:0.005330:0.006222:0.006331:0.011738:0.012604:0.015990:0.012508:0.010660:0.012508:0.003762:0.005330:0.006331:0.003848:0.011738:0.006331:0.006523:0.011738:0.012508:0.006319:0.012604:0.009583:0.256023
1:@0.729392:0.205359:0.735607:0.205359:0.735607:0.196174:0.729392:0.196174:0.006215
and Europe the rate is 4-5/100 000 and it :@0.523635:0.227687:0.919884:0.227687:0.919884:0.211931:0.523635:0.211931:0.013143:0.011738:0.013181:0.007293:0.010314:0.011699:0.005713:0.012604:0.013123:0.012508:0.007283:0.006523:0.011738:0.012508:0.007293:0.005792:0.013143:0.006523:0.012508:0.007279:0.003848:0.007466:0.007293:0.010660:0.006388:0.010660:0.008409:0.010660:0.010660:0.010660:0.007308:0.010660:0.010660:0.010660:0.007293:0.013143:0.011738:0.013181:0.007293:0.003848:0.006523:0.005330
accounts for roughly 10% of haematologi-:@0.523635:0.244395:0.914560:0.244395:0.914560:0.228639:0.523635:0.228639:0.013143:0.012450:0.012450:0.012604:0.011699:0.011738:0.006523:0.007466:0.005465:0.006042:0.012604:0.005792:0.005465:0.005711:0.012604:0.011699:0.012950:0.011738:0.003848:0.010314:0.005465:0.010660:0.010660:0.014913:0.005465:0.012604:0.006042:0.005465:0.011738:0.013143:0.012508:0.018049:0.013143:0.006523:0.012604:0.003848:0.012604:0.012950:0.003848:0.006388
cal malignancies.  The disparity with the :@0.523635:0.261103:0.919882:0.261086:0.919882:0.245330:0.523635:0.245348:0.012450:0.013143:0.003848:0.007466:0.018049:0.013143:0.003848:0.003848:0.012950:0.011738:0.013143:0.011738:0.012450:0.003848:0.012508:0.007466:0.005330:0.015547:0.007466:0.008197:0.011738:0.012508:0.007455:0.013181:0.003848:0.007466:0.013123:0.013143:0.005792:0.003848:0.006523:0.010314:0.007466:0.015990:0.003848:0.006523:0.011738:0.007466:0.006523:0.011738:0.012508:0.183149
2,3:@0.690609:0.255467:0.706146:0.255467:0.706146:0.246281:0.690609:0.246281:0.006215:0.003107:0.006215
global incidence is likely due to under-:@0.523635:0.277794:0.914544:0.277794:0.914544:0.262038:0.523635:0.262038:0.012950:0.003848:0.012604:0.013123:0.013143:0.003848:0.010660:0.003848:0.011738:0.012450:0.003848:0.013181:0.012508:0.011738:0.012450:0.012508:0.010660:0.003848:0.007466:0.010660:0.003848:0.003848:0.009660:0.012508:0.003848:0.010314:0.010660:0.013181:0.011699:0.012508:0.010660:0.006523:0.012604:0.010660:0.011699:0.011738:0.013181:0.012508:0.005792:0.006388
diagnosis (with earlier death) and under-:@0.523635:0.294503:0.914564:0.294503:0.914564:0.278747:0.523635:0.278747:0.013181:0.003848:0.013143:0.012950:0.011738:0.012604:0.007466:0.003848:0.007466:0.007697:0.007100:0.015990:0.003848:0.006523:0.011738:0.007697:0.012508:0.013143:0.005792:0.003848:0.003848:0.012508:0.005792:0.007697:0.013181:0.012508:0.013143:0.006523:0.011738:0.007100:0.007697:0.013143:0.011738:0.013181:0.007697:0.011699:0.011738:0.013181:0.012508:0.005792:0.006388
reporting in South Africa.:@0.523635:0.311211:0.753002:0.311211:0.753002:0.295455:0.523635:0.295455:0.005713:0.012508:0.013123:0.012604:0.005792:0.006523:0.003848:0.011738:0.012950:0.005330:0.003848:0.011738:0.005330:0.009583:0.012604:0.011699:0.006523:0.011738:0.005330:0.014239:0.006042:0.005792:0.003848:0.012450:0.013143:0.005330
MM occurs in all races and all geo-:@0.541819:0.327920:0.914544:0.327920:0.914544:0.312164:0.541819:0.312164:0.017684:0.017684:0.011969:0.012604:0.012450:0.012450:0.011699:0.005792:0.007466:0.011969:0.003848:0.011738:0.011969:0.013143:0.003848:0.003848:0.011969:0.005792:0.013143:0.012450:0.012508:0.007466:0.011969:0.013143:0.011738:0.013181:0.011969:0.013143:0.003848:0.003848:0.011969:0.012950:0.012508:0.012585:0.006388
graphic locations, but incidence appears :@0.523635:0.344628:0.919874:0.344628:0.919874:0.328872:0.523635:0.328872:0.012950:0.005792:0.013143:0.013123:0.011738:0.003848:0.012450:0.006100:0.003848:0.012604:0.012450:0.013143:0.006523:0.003848:0.012604:0.011738:0.007466:0.005330:0.006100:0.013123:0.011699:0.006523:0.006100:0.003848:0.011738:0.012450:0.003848:0.013181:0.012508:0.011738:0.012450:0.012508:0.006100:0.013143:0.013123:0.013123:0.012508:0.013143:0.005792:0.007466:0.005330
to vary with sex and ethnicity. MM is twice :@0.523635:0.361337:0.919892:0.361337:0.919892:0.345581:0.523635:0.345581:0.006523:0.012604:0.005453:0.010660:0.013143:0.005792:0.010314:0.005465:0.015990:0.003848:0.006523:0.011738:0.005465:0.007466:0.012508:0.009236:0.005465:0.013143:0.011738:0.013181:0.005465:0.012508:0.006523:0.011738:0.011738:0.003848:0.012450:0.003848:0.006523:0.010314:0.005330:0.005455:0.017684:0.017684:0.005465:0.003848:0.007466:0.005465:0.006523:0.015990:0.003848:0.012450:0.012508:0.005330
as common in blacks compared to Cau-:@0.523635:0.378045:0.914558:0.378045:0.914558:0.362289:0.523635:0.362289:0.013143:0.007466:0.007139:0.012450:0.012604:0.018049:0.018049:0.012604:0.011738:0.007120:0.003848:0.011738:0.007127:0.013123:0.003848:0.013143:0.012450:0.009660:0.007466:0.007139:0.012450:0.012604:0.018049:0.013123:0.013143:0.005713:0.012508:0.013181:0.007125:0.006523:0.012604:0.007122:0.015644:0.013143:0.011699:0.006388
casians   and  is slightly more  frequent  in :@0.523635:0.394753:0.919883:0.394706:0.919883:0.378950:0.523635:0.378998:0.012450:0.013143:0.007466:0.003848:0.013143:0.011738:0.007466:0.015553:0.005330:0.003315:0.013143:0.011738:0.013181:0.005330:0.003315:0.003848:0.007466:0.008659:0.007466:0.003848:0.003848:0.012950:0.011738:0.006523:0.003848:0.010314:0.008659:0.018049:0.012604:0.005707:0.012508:0.005330:0.003315:0.006042:0.005711:0.012508:0.013123:0.011699:0.012508:0.011738:0.006523:0.005330:0.003308:0.003848:0.011738:-0.011209
4,5:@0.592901:0.389087:0.608438:0.389087:0.608438:0.379902:0.592901:0.379902:0.006215:0.003107:0.006215
men  than women.  MM is typically a dis-:@0.523640:0.411415:0.914547:0.411415:0.914547:0.395659:0.523640:0.395659:0.018049:0.012508:0.011738:0.005330:0.003396:0.006523:0.011738:0.013143:0.011738:0.008736:0.015990:0.012604:0.018049:0.012508:0.011738:0.005330:0.005330:0.003394:0.017684:0.017684:0.008736:0.003848:0.007466:0.008736:0.006523:0.010314:0.013123:0.003848:0.012450:0.013143:0.003848:0.003848:0.010314:0.008736:0.013143:0.008736:0.013181:0.003848:0.007466:0.006388
ease of older adults, with a median age at :@0.523640:0.428123:0.919899:0.428123:0.919899:0.412367:0.523640:0.412367:0.012508:0.013143:0.007466:0.012508:0.004445:0.012604:0.006042:0.004445:0.012604:0.003848:0.013181:0.012508:0.005792:0.004445:0.013143:0.013181:0.011699:0.003848:0.006523:0.007466:0.005330:0.004445:0.015990:0.003848:0.006523:0.011738:0.004445:0.013143:0.004445:0.018049:0.012508:0.013181:0.003848:0.013143:0.011738:0.004445:0.013143:0.012950:0.012508:0.004445:0.013143:0.006523:0.005330
diagnosis of 66 years, and only 2% of pa-:@0.523640:0.444832:0.914505:0.444832:0.914505:0.429076:0.523640:0.429076:0.013181:0.003848:0.013143:0.012950:0.011738:0.012604:0.007466:0.003848:0.007466:0.007095:0.012604:0.006042:0.007081:0.010660:0.010660:0.007081:0.010314:0.012508:0.013143:0.005792:0.007466:0.005330:0.007081:0.013143:0.011738:0.013181:0.007081:0.012604:0.011738:0.003848:0.010314:0.007081:0.010660:0.014913:0.007081:0.012604:0.006042:0.007081:0.013123:0.013143:0.006388
tients are under the age of 40.  In Africa, :@0.523640:0.461540:0.919882:0.461517:0.919882:0.445761:0.523640:0.445784:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.007277:0.013143:0.005713:0.012508:0.007277:0.011699:0.011738:0.013181:0.012508:0.005792:0.007276:0.006523:0.011738:0.012508:0.007274:0.013143:0.012950:0.012508:0.007276:0.012604:0.006042:0.007276:0.010660:0.010660:0.005330:0.006214:0.007279:0.004349:0.011738:0.007279:0.014239:0.006042:0.005792:0.003848:0.012450:0.013143:0.005330:-0.108386
5:@0.816845:0.455897:0.823060:0.455897:0.823060:0.446712:0.816845:0.446712:0.006215
a five- to 10-year younger median age is :@0.523631:0.478225:0.919857:0.478225:0.919857:0.462469:0.523631:0.462469:0.013143:0.007183:0.004686:0.004686:0.010660:0.012508:0.006388:0.007179:0.006523:0.012604:0.007175:0.010660:0.010660:0.006388:0.010314:0.012508:0.013143:0.005792:0.007179:0.010314:0.012604:0.011699:0.011738:0.012950:0.012508:0.005792:0.007166:0.018049:0.012508:0.013181:0.003848:0.013143:0.011738:0.007185:0.013143:0.012950:0.012508:0.007179:0.003848:0.007466:0.005330
described,  however newer and large :@0.523631:0.494933:0.919870:0.494922:0.919870:0.479166:0.523631:0.479177:0.013181:0.012508:0.007466:0.012450:0.005792:0.003848:0.013123:0.012508:0.013181:0.005330:0.006222:0.014663:0.011738:0.012604:0.015990:0.012508:0.010660:0.012508:0.005792:0.014663:0.011738:0.012508:0.015990:0.012508:0.005782:0.014663:0.013143:0.011738:0.013181:0.014663:0.003848:0.013143:0.005813:0.012950:0.012508:-0.156964
6:@0.623024:0.489303:0.629238:0.489303:0.629238:0.480117:0.623024:0.480117:0.006215
population-based data are needed from :@0.523638:0.511630:0.919893:0.511630:0.919893:0.495874:0.523638:0.495874:0.013123:0.012604:0.013123:0.011699:0.003848:0.013143:0.006523:0.003848:0.012604:0.011738:0.006388:0.013123:0.013143:0.007466:0.012508:0.013181:0.006870:0.013181:0.013143:0.006523:0.013143:0.006870:0.013143:0.005713:0.012508:0.006870:0.011738:0.012508:0.012508:0.013181:0.012508:0.013181:0.006870:0.006042:0.005713:0.012604:0.018049:0.005330
southern Africa. A higher incidence of MM :@0.523638:0.528339:0.919884:0.528339:0.919884:0.512583:0.523638:0.512583:0.007466:0.012604:0.011699:0.006523:0.011738:0.012508:0.006183:0.011738:0.004753:0.014239:0.006042:0.005792:0.003848:0.012450:0.013143:0.005330:0.004753:0.014239:0.004753:0.011738:0.003848:0.012950:0.011738:0.012508:0.005792:0.004753:0.003848:0.011738:0.012450:0.003848:0.013181:0.012508:0.011738:0.012450:0.012508:0.004753:0.012604:0.006042:0.004753:0.017684:0.017684:0.005330
is seen in HIV-infected persons.:@0.523638:0.545047:0.808291:0.545047:0.808291:0.529291:0.523638:0.529291:0.003848:0.007466:0.005330:0.007466:0.012508:0.012508:0.011738:0.005330:0.003848:0.011738:0.005330:0.013143:0.004349:0.013508:0.006388:0.003848:0.011738:0.006042:0.012508:0.012450:0.006523:0.012508:0.013181:0.005330:0.013123:0.012508:0.005792:0.007466:0.012604:0.011738:0.007466:0.005330
7,8:@0.808279:0.539410:0.823816:0.539410:0.823816:0.530225:0.808279:0.530225:0.006215:0.003107:0.006215
PATHOPHYSIOLOGY:@0.523636:0.579081:0.746591:0.579081:0.746591:0.559485:0.523636:0.559485:0.013170:0.017404:0.009878:0.015993:0.019756:0.013170:0.015993:0.014581:0.012230:0.006585:0.019756:0.010348:0.019756:0.019756:0.014581
The pathophysiology for the development :@0.523636:0.598077:0.919891:0.598077:0.919891:0.582321:0.523636:0.582321:0.007812:0.011353:0.012123:0.008293:0.012738:0.012758:0.006138:0.011353:0.012219:0.012738:0.011353:0.009929:0.007081:0.003464:0.012219:0.003464:0.012219:0.012565:0.009929:0.008293:0.005657:0.012219:0.005407:0.008293:0.006138:0.011353:0.012123:0.008293:0.012796:0.012123:0.010275:0.012123:0.003464:0.012219:0.012738:0.017665:0.012123:0.011353:0.006519:0.005330
of MM can be conceptualised as a two-:@0.523636:0.615076:0.914564:0.615076:0.914564:0.599320:0.523636:0.599320:0.012219:0.005657:0.008967:0.017299:0.017299:0.008967:0.012065:0.012758:0.011353:0.008967:0.012738:0.012123:0.008967:0.012065:0.012219:0.011353:0.012065:0.012123:0.012738:0.006138:0.011315:0.012758:0.003464:0.003464:0.007081:0.012123:0.012796:0.008967:0.012758:0.007081:0.008967:0.012758:0.008967:0.006138:0.015606:0.012219:0.006388
step process: initial production of a plasma :@0.523636:0.632076:0.919833:0.632076:0.919833:0.616320:0.523636:0.616320:0.007081:0.006138:0.012123:0.012738:0.006331:0.012738:0.005326:0.012219:0.012065:0.012123:0.007081:0.007081:0.004945:0.006331:0.003464:0.011353:0.003464:0.006138:0.003464:0.012758:0.003464:0.006331:0.012738:0.005328:0.012219:0.012796:0.011315:0.012065:0.006138:0.003464:0.012219:0.011353:0.006331:0.012219:0.005657:0.006331:0.012758:0.006331:0.012738:0.003464:0.012758:0.007081:0.017665:0.013144:0.005330
cell clone producing a monoclonal im-:@0.523636:0.649075:0.914580:0.649075:0.914580:0.633319:0.523636:0.633319:0.012065:0.012123:0.003464:0.003464:0.013143:0.012065:0.003464:0.012219:0.011353:0.012123:0.013143:0.012738:0.005326:0.012219:0.012796:0.011315:0.012065:0.003464:0.011353:0.012565:0.013143:0.012758:0.013143:0.017665:0.012219:0.011353:0.012219:0.012065:0.003464:0.012219:0.011353:0.012758:0.003464:0.013143:0.003464:0.017665:0.006388
munoglobulin  and then a “second-hit” re-:@0.523636:0.666075:0.914565:0.666063:0.914565:0.650307:0.523636:0.650319:0.017665:0.011315:0.011353:0.012219:0.012565:0.003464:0.012219:0.012738:0.011315:0.003464:0.003464:0.011738:0.005602:0.006908:0.012758:0.011353:0.012796:0.006908:0.006138:0.011353:0.012123:0.011353:0.006908:0.012758:0.006908:0.009275:0.007081:0.012123:0.012065:0.012219:0.011353:0.012796:0.006004:0.011353:0.003464:0.006138:0.008928:0.006908:0.005328:0.012123:-0.399532
9:@0.646762:0.660444:0.652976:0.660444:0.652976:0.651258:0.646762:0.651258:0.006215
sulting in the proliferation of the malignant :@0.523638:0.683063:0.919872:0.683063:0.919872:0.667307:0.523638:0.667307:0.007081:0.011315:0.003464:0.006138:0.003464:0.011353:0.012565:0.007562:0.003464:0.011353:0.007562:0.006138:0.011353:0.012123:0.007562:0.012738:0.005328:0.012219:0.003464:0.003464:0.005657:0.012123:0.005407:0.012758:0.006138:0.003464:0.012219:0.011353:0.007562:0.012219:0.005657:0.007562:0.006138:0.011353:0.012123:0.007562:0.017665:0.012758:0.003464:0.003464:0.012565:0.011353:0.012758:0.011353:0.006519:0.005330
clone. While some steps in the process have :@0.523638:0.700062:0.919893:0.700062:0.919893:0.684306:0.523638:0.684306:0.012065:0.003464:0.012219:0.011353:0.012123:0.004945:0.004580:0.018088:0.011353:0.003464:0.003464:0.012123:0.004580:0.007081:0.012219:0.017665:0.012123:0.004580:0.007081:0.006138:0.012123:0.012738:0.007081:0.004580:0.003464:0.011353:0.004580:0.006138:0.011353:0.012123:0.004580:0.012738:0.005328:0.012219:0.012065:0.012123:0.007081:0.007081:0.004580:0.011353:0.012758:0.010275:0.012506:0.005330
been elucidated, many remain unknown.:@0.523638:0.717062:0.897937:0.717062:0.897937:0.701306:0.523638:0.701306:0.012738:0.012123:0.012123:0.011353:0.004945:0.012123:0.003464:0.011315:0.012065:0.003464:0.012796:0.012758:0.006138:0.012123:0.012796:0.004945:0.004945:0.017665:0.012758:0.011353:0.009929:0.004945:0.005326:0.012123:0.017665:0.012758:0.003464:0.011353:0.004945:0.011315:0.011353:0.009275:0.011353:0.012219:0.015606:0.011353:0.005330
In  the  first  step,  a  combination  of  ge-:@0.541822:0.734061:0.914561:0.734061:0.914561:0.718305:0.541822:0.718305:0.004349:0.011738:0.005330:0.004453:0.006523:0.011738:0.012508:0.005330:0.004453:0.004686:0.004686:0.005792:0.007466:0.006523:0.005330:0.004451:0.007466:0.006523:0.012508:0.013123:0.005330:0.005330:0.004455:0.013143:0.005330:0.004457:0.012450:0.012604:0.018049:0.013123:0.003848:0.011738:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330:0.004449:0.012604:0.006042:0.005330:0.004451:0.012950:0.012508:0.006388
netic susceptibility  with an aberrant  re-:@0.523638:0.751060:0.914567:0.751060:0.914567:0.735305:0.523638:0.735305:0.011738:0.012508:0.006523:0.003848:0.012450:0.011584:0.007466:0.011699:0.007466:0.012450:0.012508:0.013123:0.006523:0.003848:0.013123:0.003848:0.003848:0.003848:0.006523:0.010314:0.005330:0.006269:0.015990:0.003848:0.006523:0.011738:0.011584:0.013143:0.011738:0.011584:0.013143:0.013123:0.012508:0.005792:0.005792:0.013143:0.011738:0.006523:0.005330:0.006240:0.005713:0.012508:0.006388
sponse to antigenic stimulation results in :@0.523638:0.768060:0.919854:0.768060:0.919854:0.752304:0.523638:0.752304:0.007466:0.013123:0.012604:0.011738:0.007466:0.012508:0.009602:0.006523:0.012604:0.009602:0.013143:0.011738:0.006523:0.003848:0.012950:0.012508:0.011738:0.003848:0.012450:0.009602:0.007466:0.006523:0.003848:0.018049:0.011699:0.003848:0.013143:0.006523:0.003848:0.012604:0.011738:0.009602:0.005711:0.012508:0.007466:0.011699:0.003848:0.006523:0.007466:0.009602:0.003848:0.011738:0.005330
cytogenetic  abnormalities (usually in the :@0.523638:0.785059:0.919866:0.785059:0.919866:0.769303:0.523638:0.769303:0.012450:0.010314:0.006523:0.012604:0.012950:0.012508:0.011738:0.012508:0.006523:0.003848:0.012450:0.005330:0.003369:0.013143:0.013123:0.011738:0.012604:0.006317:0.018049:0.013143:0.003848:0.003848:0.006523:0.003848:0.012508:0.007466:0.008717:0.007100:0.011699:0.007466:0.011699:0.013143:0.003848:0.003848:0.010314:0.008717:0.003848:0.011738:0.008717:0.006523:0.011738:0.012508:0.005330
immunoglobulin heavy chain (IgH) lo-:@0.523638:0.802059:0.914547:0.802059:0.914547:0.786303:0.523638:0.786303:0.003848:0.018049:0.018049:0.011699:0.011738:0.012604:0.012950:0.003848:0.012604:0.013123:0.011699:0.003848:0.003848:0.011738:0.015625:0.011738:0.012508:0.013143:0.010660:0.010314:0.015625:0.012450:0.011738:0.013143:0.003848:0.011738:0.015625:0.007100:0.004349:0.012950:0.013143:0.007100:0.015625:0.003848:0.012604:0.006388
cus) , which results in the presence of a :@0.523638:0.819058:0.919881:0.819032:0.919881:0.803276:0.523638:0.803302:0.012450:0.011699:0.007466:0.007100:0.012436:0.005330:0.008182:0.015990:0.011738:0.003848:0.012450:0.011738:0.008184:0.005711:0.012508:0.007466:0.011699:0.003848:0.006523:0.007466:0.008197:0.003848:0.011738:0.008186:0.006523:0.011738:0.012508:0.008178:0.013123:0.005715:0.012508:0.007466:0.012508:0.011738:0.012450:0.012508:0.008180:0.012604:0.006042:0.008180:0.013143:-0.628407
10:@0.562355:0.813413:0.574785:0.813413:0.574785:0.804227:0.562355:0.804227:0.006215:0.006215
dominant plasma cell clone. In this stage, :@0.523643:0.836031:0.919887:0.836031:0.919887:0.820275:0.523643:0.820275:0.013181:0.012604:0.018049:0.003848:0.011738:0.013143:0.011738:0.006523:0.006100:0.013123:0.003848:0.013143:0.007466:0.018049:0.013143:0.006113:0.012450:0.012508:0.003848:0.003848:0.006100:0.012450:0.003848:0.012604:0.011738:0.012508:0.005330:0.006090:0.004349:0.011738:0.006100:0.006523:0.011738:0.003848:0.007466:0.006100:0.007466:0.006523:0.013143:0.012950:0.012508:0.005330:0.005330
a patient would be clinically diagnosed :@0.523643:0.853031:0.919885:0.853031:0.919885:0.837275:0.523643:0.837275:0.013143:0.009487:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.009487:0.015990:0.012604:0.011699:0.003848:0.013181:0.009487:0.013123:0.012508:0.009487:0.012450:0.003848:0.003848:0.011738:0.003848:0.012450:0.013143:0.003848:0.003848:0.010335:0.009487:0.013181:0.003848:0.013143:0.012950:0.011738:0.012604:0.007466:0.012508:0.013181:0.005330
with MGUS (or SMM). The variable rate of :@0.523643:0.870030:0.919908:0.870030:0.919908:0.854274:0.523643:0.854274:0.015990:0.003848:0.006523:0.011738:0.006889:0.017684:0.016779:0.012604:0.009583:0.006879:0.007100:0.012604:0.005792:0.006879:0.009583:0.017684:0.017684:0.007100:0.005330:0.006889:0.008197:0.011738:0.012508:0.006875:0.010660:0.013143:0.005792:0.003848:0.013143:0.013123:0.003848:0.012508:0.006889:0.005792:0.013143:0.006523:0.012508:0.006889:0.012604:0.006042:0.005330
progression is evidenced by the fact that :@0.523643:0.886739:0.919873:0.886739:0.919873:0.870983:0.523643:0.870983:0.013123:0.005715:0.012604:0.012950:0.005705:0.012508:0.007466:0.007466:0.003848:0.012604:0.011738:0.006831:0.003848:0.007466:0.006831:0.012508:0.010660:0.003848:0.013181:0.012508:0.011738:0.012450:0.012508:0.013181:0.006831:0.013123:0.010314:0.006831:0.006523:0.011738:0.012508:0.006831:0.006042:0.013143:0.012450:0.006523:0.006831:0.006523:0.011738:0.013143:0.006523:0.005330
MGUS is present in over 3% of the popula-:@0.523643:0.903447:0.914528:0.903447:0.914528:0.887691:0.523643:0.887691:0.017684:0.016779:0.012604:0.009583:0.005907:0.003848:0.007466:0.005907:0.013123:0.005715:0.012508:0.007466:0.012508:0.011738:0.006523:0.005907:0.003848:0.011738:0.005907:0.012604:0.010660:0.012508:0.005792:0.005907:0.010660:0.014913:0.005915:0.012604:0.006042:0.005913:0.006523:0.011738:0.012508:0.005907:0.013123:0.012604:0.013123:0.011699:0.003848:0.013143:0.006388
tion over the age of 50 but only progresses :@0.523643:0.919851:0.919879:0.919851:0.919879:0.904095:0.523643:0.904095:0.006523:0.003848:0.012604:0.011738:0.004737:0.012604:0.010660:0.012508:0.005792:0.004739:0.006523:0.011738:0.012508:0.004737:0.013143:0.012950:0.012508:0.004743:0.012604:0.006042:0.004737:0.010660:0.010660:0.004753:0.013123:0.011699:0.006523:0.004741:0.012604:0.011738:0.003848:0.010314:0.004743:0.013123:0.005715:0.012604:0.012950:0.005705:0.012508:0.007466:0.007466:0.012508:0.007466:0.005330
to MM or a related malignancy at a rate :@0.523643:0.936256:0.919898:0.936256:0.919898:0.920500:0.523643:0.920500:0.006523:0.012604:0.006927:0.017684:0.017684:0.006933:0.012604:0.005792:0.006931:0.013143:0.006935:0.005713:0.012508:0.003848:0.013143:0.006523:0.012508:0.013181:0.006931:0.018049:0.013143:0.003848:0.003848:0.012950:0.011738:0.013143:0.011738:0.012450:0.010314:0.006947:0.013143:0.006523:0.006933:0.013143:0.006937:0.005792:0.013143:0.006523:0.012508:0.005330
Multiple Myeloma:@0.084848:0.111850:0.456868:0.111850:0.456868:0.076219:0.084848:0.076219:0.038485:0.025657:0.010263:0.012828:0.010263:0.028222:0.010263:0.027367:0.011973:0.038485:0.024801:0.027367:0.010263:0.027367:0.040195:0.028222